Latigo Biotherapeutics prices $345.6M IPO at $18 per share
Investing.com· Investing.com· Aug 7, 2026 · 12:15 AM
This is a summary. Read the complete story at Investing.com below.
Read full article at Investing.comRelated Stories
stocksabout 4 hours ago
Exclusive-Anthropic considers releasing new AI model ahead of IPO, sources say
Investing.com
stocksabout 4 hours ago
Morgan Stanley private credit fund redemption requests remain elevated in third quarter
Investing.com
stocksabout 4 hours ago
Gemini hacked three companies in first known breakout by Google’s AI
Investing.com